Data gathered: November 22
Alternative Data for Artivion
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 18,000 | Sign up | Sign up | Sign up |
| Google Trends | 42 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 319 | Sign up | Sign up | Sign up |
| Twitter Mentions | 19 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Artivion
Artivion Inc. manufactures, processes and distributes implantable human tissues and medical devices worldwide.
| Price | $28.54 |
| Target Price | Sign up |
| Volume | 78,170 |
| Market Cap | $1.14B |
| Year Range | $19.62 - $29.44 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Medical Devices |
In the news
Artivion Third Quarter 2024 Earnings: Beats ExpectationsNovember 8 - Yahoo |
|
 |
Artivion, Inc. (AORT) Q3 2024 Earnings Call TranscriptNovember 8 - SeekingAlpha |
 |
Artivion Reports Third Quarter 2024 Financial ResultsNovember 7 - Yahoo |
Artivion: Q3 Earnings SnapshotNovember 7 - Finnhub |
|
|
Artivion to Participate in Upcoming Investor ConferencesNovember 5 - Yahoo |
 |
Head to Head Survey: Artivion (NYSE:AORT) and Odyssey Health (OTCMKTS:ODYY)October 30 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 96M | 89M | 61M | -2.3M | 11M | 0.000 |
| Q2 '24 | 98M | 88M | 63M | -2.1M | 9.8M | -0.050 |
| Q1 '24 | 86M | 69M | 63M | 7.5M | 25M | 0.060 |
| Q4 '23 | 90M | 86M | 61M | -4M | 9.5M | -0.100 |
| Q3 '23 | 81M | 87M | 56M | -9.8M | 1.1M | -0.240 |
Insider Transactions View All
| Horton Amy filed to sell 139,989 shares at $26.2. October 2 '24 |
| Holloway Jean F filed to sell 161,932 shares at $26.6. August 27 '24 |
| Getz Matthew A filed to sell 34,116 shares at $25.3. August 19 '24 |
| Getz Matthew A filed to sell 36,678 shares at $25.3. August 19 '24 |
| Holloway Jean F filed to sell 165,099 shares at $25.8. August 16 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Christine Smith Democrat |
Nov 20, 23 | Buy | $50K - $100K |
| Christine Smith Democrat |
Nov 20, 23 | Buy | $50K - $100K |
| Joshua Gottheimer Democrat |
Aug 21, 23 | Buy | $1K - $15K |
Read more about Artivion (AORT) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of Artivion?
The Market Cap of Artivion is $1.14B.
What is the current stock price of Artivion?
Currently, the price of one share of Artivion stock is $28.54.
How can I analyze the AORT stock price chart for investment decisions?
The AORT stock price chart above provides a comprehensive visual representation of Artivion's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Artivion shares. Our platform offers an up-to-date AORT stock price chart, along with technical data analysis and alternative data insights.
Does AORT offer dividends to its shareholders?
As of our latest update, Artivion (AORT) does not offer dividends to its shareholders. Investors interested in Artivion should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Artivion?
Some of the similar stocks of Artivion are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.